FDA Working To Put A Price Tag On Ensuring Safety Of Personal Drug Imports
This article was originally published in The Pink Sheet Daily
Executive Summary
The number of personal imports is “overwhelming,” FDA’s McGinnis says. The National Association of Boards of Pharmacy reports it has collected approximately 100 reports of patient harm from imported products.